Clinical Trials Logo

Filter by:
NCT ID: NCT06333405 Not yet recruiting - Clinical trials for Necrotizing Enterocolitis

Fecal Microbiota Transplantation (FMT) as a Prophylaxis of Necrotizing Enterocolitis (NEC) - Clinical Study

Start date: May 1, 2024
Phase: N/A
Study type: Interventional

The aim of the study is to assess the safety of fecal microbiota transplantation (FMT) as a preventive method for the development of Necrotizing enterocolitis (NEC) in a group of premature infants. This is the first stage of a clinical trial testing the effectiveness of FMT in NEC, the aim of which is to examine the safety profile and analyze all side effects.

NCT ID: NCT06328504 Not yet recruiting - Food Allergy Clinical Trials

Efficacy of Cashew Nut Protein Immunotherapy

Start date: March 2024
Phase: N/A
Study type: Interventional

It is a randomized, sigle-center, controlled trial to evaluate the effectiveness of oral immunotherapy with cashew protein compared with standard treatment (elimination diet) in pediatric patients with cashew allergy.

NCT ID: NCT06304324 Not yet recruiting - Foot Diseases Clinical Trials

Dexmedetomidine vs Dexamethasone in Popliteal Nerve Block

Start date: April 1, 2024
Phase: Phase 4
Study type: Interventional

Effect of Perineural Dexmedetomidine vs. Dexamethasone on the duration of popliteal nerve block for Anesthesia After Pediatric ankle/foot surgery.

NCT ID: NCT06302218 Not yet recruiting - Knee Osteoarthritis Clinical Trials

ESPB vs iPACK+ACB in Total Knee Arthroplasty

Start date: April 1, 2024
Phase: Phase 4
Study type: Interventional

Effect of iPACK block with Adductor Canal Block and ESPB on pain management, and NLR and PLR following knee arthroplasty

NCT ID: NCT06297096 Not yet recruiting - Systemic Sclerosis Clinical Trials

Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease

NINTOC-TU
Start date: April 1, 2024
Phase: Phase 3
Study type: Interventional

The study includes adult patients with systemic sclerosis (SSc) with interstitial lung disease (ILD) to evaluate the efficacy and safety of nintedanib plus tocilizumab combination therapy compared to standard therapy (methotrexate, mycophenolate mofetil) for 56 weeks.

NCT ID: NCT06292988 Not yet recruiting - Clinical trials for Medullary Thyroid Cancer

Predictive Factors for Medullary Thyroid Cancer Aggressiveness

MYELO
Start date: March 1, 2024
Phase:
Study type: Observational

This study is a retrospective study trying to find the predictive factors for medullary thyroid aggressiveness in terms of tumor metastasis and patients' survival.

NCT ID: NCT06290843 Not yet recruiting - Clinical trials for Idiopathic Scoliosis

Analysis of Body Balance Parameters in Children With Idiopathic Scoliosis

Start date: April 5, 2024
Phase:
Study type: Observational

The aim of the study is to compare body balance parameters assessed using the AMTI dynamometric platform in children with idiopathic scoliosis (with and without Schroth therapy) compared to control group.

NCT ID: NCT06289790 Not yet recruiting - Clinical trials for Thoracic Surgery, Video-Assisted

Erector Spinae Plane (ESP) Block vs Intravenous Lignocaine Infusion in (VATS)

Start date: February 26, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare analgesic efficacy of erector spinae plane (ESP) block vs intravenous lignocaine infusion in video- assisted thoracoscopy (VATS. The main goals are to compare post- operative pain scores and cumulative post- operative opioid doses in both groups

NCT ID: NCT06289231 Not yet recruiting - Gait Clinical Trials

The Use of Artificial Intelligence (AI) for Gait Analysis

Start date: May 2024
Phase:
Study type: Observational

The main purpose of this study will be to assess the consistency and reliability of measurements made using the Vicon three-plane gait analysis device (Vicon Motion Capture System Ltd, Oxford, UK) and a mobile application based on image recognition technology with the help of artificial intelligence.

NCT ID: NCT06283407 Not yet recruiting - Clinical trials for Musculoskeletal Diseases or Conditions

ICF-based Comparison on Musculoskeletal Health in Poland and Spain

Start date: March 4, 2024
Phase:
Study type: Observational

Musculoskeletal conditions are a major cause of disability worldwide. These conditions are often associated with chronicity, which is a challenge for healthcare systems to address. Health care must be person-centred and take into account the individual perspective from which the disease is experienced. The lived experience of health conditions depends to a large extent on contextual factors. Comparison between different contexts helps to identify which aspects are most relevant in the experience of the disease. The International Classification of Functioning, Disability and Health (ICF) provides a unified language that allows such comparisons to be made. The aim of this study is to identify differences in musculoskeletal health between the Polish and Spanish populations using the ICF as a frame of reference.